A Aralex Aachen research explorer

June 07, 2018 conference-abstract

Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1): A randomized, controlled, multicenter phase III trial.

Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.18_suppl.lba4002 OpenAlex

Authors 0

Author list not loaded yet.

Cited by 3 stored of 161

Refining the Classroom: The Self-Supervised Professor Model for Improved Segmentation of Locally Advanced Pancreatic Ductal Adenocarcinoma
2025 Journal of Imaging Informatics in Medicine article Computer Science Medical Image Segmentation Techniques Open access

0

citations
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial
2025 The Lancet Oncology article Medicine Pancreatic and Hepatic Oncology Research Open access

53

citations
Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial
2021 BMC Cancer article Medicine Pancreatic and Hepatic Oncology Research Open access

168

citations

3 results

References 0